Biotech Values

[rfj1862]

Is that code for "not statistically significant, may be better or worse than placebo"?

I think like 10 minutes of research could answer your question.

I ordinarily do not get super enthusiastic about about any of my investments, but in this particular case there is no doubt that the therapy has considerable efficacy (in hematologic malignancies, at least), the mechanism is crystal clear and makes sense, and if it is indeed effective at providing any efficacy whatsoever in pancreatic has absolutely ridiculous potential. Even if the pancreatic trial ends up being a flop there's still the hematologic malignancies where they already demonstrated efficacy.

Also since all of these trials are being conducted at Baylor and reported by the investigators there's minimal to no scam potential.